• Home
  • PR



게시물 상세
OliX Pharmaceuticals Announces Completion of $37.2 Million Capital Raise
Date : 2020-12-04     View : 2129

OliX Pharmaceuticals Announces Completion of $37.2 Million Capital Raise to Support U.S. Expansion and Advance Pipeline Globally


- Capital to fund construction of RNA synthesis GMP facility in San Diego 

- Supports company’s goal of having 10 programs entered into clinical trials by 2024

Learn more: https://apnews.com/press-release/globe-newswire/technology-business-health-pharmaceutical-manufacturing-health-care-industry-e9241a601ec0a5f8c3b546e882b78fe3 

Source _ OliX Pharmaceuticals

Prev OliX Pharmaceuticals Launches New Subsidiary to Develop mRNA Vaccines and Therapeutics
Next OliX Announces FDA Clearance of the Phase 2a Clinical Trial IND for Hypertrophic Scars